Additionally, IHC was adopted to evaluate the expression of EMT‐associated genes, including E‐cadherin and vimentin, in primary tumor (Figure 4B) and lymph node metastatic tumor (Figure 4C). The gene discussed is CDH1; the disease is neoplasm.